drugset / Trial / NCT00645372
A Study to Compare the Efficacy and Safety of Ziprasidone and Risperidone for the Treatment of Schizophrenia in Chinese Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to compare the efficacy and safety of ziprasidone and risperidone for the treatment of schizophrenia in Chinese patients
Timeline
- Start
- 2004-07
- Primary completion
- —
- Completion
- 2005-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Risperidone | Other / unclassified | 1 mg | Oral |
| Comparator | Risperidone | Other / unclassified | 2 mg | Oral |
| Comparator | Risperidone | Other / unclassified | 3 mg | Oral |
| Subject | Ziprasidone | Small molecule | 40 mg | Oral |
| Subject | Ziprasidone | Small molecule | 60 mg | Oral |
| Subject | Ziprasidone | Small molecule | 80 mg | Oral |